中文

← All funding rounds

Zhichong Pharma

ChinaDrug discoverySuzhou, ChinaPrivate

Develops new drugs for pets with generative AI, using its own small-molecule and large-molecule design engines (ChemoFetch and OmniFetch), and argues that testing in the target animal closes the loop from design to evidence faster than human drug development can; its programmes are in anti-infectives, chronic disease and ageing.

Disclosed total-
Rounds on record2
Latest roundtens of millions of yuanSeries A1 · 2026-10-23
Last stated valuationNone stated
Investors named3
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date202420252026AngelSeries A1
Closed roundNot on the dollar scale (a range, or no rate)

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-10-23Series A1
    Round

    tens of millions of yuan

    For: clinical work on its lead programmes, its end-to-end AI drug-design platform, and new programmes in anti-infectives, chronic disease, the brain and ageing

    Toward the clinicModels and platform

    First reported by VCBeat with the founder Wenjuan Wei and Dan Zhao, a partner at the lead, quoted. No valuation. Tianhui Capital is the name the source gives for the lead (Tianhui Hongyou and Tianhui Sumintou); the English is pinyin.

    Lead · Tianhui Capital

    On the deal: Dan Zhao (Partner; spoke for the lead in the announcement, Tianhui Capital)

    Advisers: Index Capital (exclusive financial adviser)

    Announced by the company · news.qq.com ↗On the timeline →

  2. 2023-07-06Angel
    Round

    tens of millions of yuan

    For: clinical development of ZC001 for feline infectious peritonitis

    Toward the clinic

    PEdaily's report of 6 July 2023 says the company was founded in 2022; the 2026 report says 2023, so no founding year is recorded here.

    Lead · Legend StarMiraclePlus

    Reported by PEdaily · news.pedaily.cn ↗

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

Its investors also backed

Other companies on this page whose rounds name the same investor.